Innovus Pharmaceuticals Inc Financial Statements (2025 and earlier)
Company Profile
| Business Address |
8845 REHCO ROAD SAN DIEGO, CA 92121 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2019 MRQ | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,248 | 1,565 | 830 | 56 | 7 | 33 | |||
| Cash and cash equivalent | 1,248 | 1,565 | 830 | 56 | 7 | 33 | |||
| Receivables | 282 | 68 | 34 | 83 | 192 | 217 | |||
| Inventory, net of allowances, customer advances and progress billings | 2,370 | 1,726 | 600 | 254 | 266 | 178 | |||
| Inventory | 2,370 | 1,726 | 600 | 254 | 266 | 178 | |||
| Prepaid expense | 1,116 | 363 | 864 | 53 | 55 | 35 | |||
| Deposits current assets | 21 | ||||||||
| Other undisclosed current assets | 98 | ||||||||
| Total current assets: | 5,016 | 3,722 | 2,327 | 544 | 520 | 484 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 247 | 62 | 30 | 35 | 55 | 79 | |||
| Intangible assets, net (including goodwill) | 4,843 | 5,226 | 5,856 | 5,850 | 1,485 | 1,295 | |||
| Goodwill | 953 | 953 | 953 | 549 | 429 | 421 | |||
| Intangible assets, net (excluding goodwill) | 3,890 | 4,273 | 4,903 | 5,301 | 1,055 | 874 | |||
| Deposits noncurrent assets | 21 | 15 | 15 | 22 | 22 | ||||
| Other undisclosed noncurrent assets | 21 | 233 | |||||||
| Total noncurrent assets: | 5,111 | 5,309 | 5,900 | 5,900 | 1,561 | 1,629 | |||
| TOTAL ASSETS: | 10,127 | 9,031 | 8,227 | 6,445 | 2,081 | 2,113 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 2,622 | 3,428 | 1,463 | 986 | 959 | ||||
| Interest and dividends payable | 4 | 48 | 79 | 53 | |||||
| Employee-related liabilities | 1,118 | 768 | 907 | 907 | |||||
| Accounts payable | 1,845 | 2,306 | 647 | ||||||
| Accrued liabilities | 237 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 540 | ||||||||
| Debt | 3,339 | 1,305 | 627 | 304 | 314 | 370 | |||
| Contract with customer, liability | ✕ | 108 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 1,284 | 413 | 1,942 | 1,440 | (520) | 718 | |||
| Total current liabilities: | 7,353 | 5,146 | 4,031 | 2,729 | 754 | 1,088 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 55 | 25 | 24 | 511 | |||||
| Long-term debt, excluding current maturities | 55 | 25 | 24 | 511 | |||||
| Liabilities, other than long-term debt | 1,437 | ||||||||
| Deferred rent credit | 181 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Business combination, contingent consideration, liability | 1,256 | ✕ | |||||||
| Other undisclosed noncurrent liabilities | 1,228 | 2,982 | 3,048 | 4,137 | 1,729 | 572 | |||
| Total noncurrent liabilities: | 2,665 | 2,982 | 3,102 | 4,162 | 1,753 | 1,083 | |||
| Total liabilities: | 10,018 | 8,128 | 7,133 | 6,891 | 2,507 | 2,172 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 109 | 903 | 1,094 | (446) | (426) | 148 | |||
| Common stock | 2 | 167 | 122 | 47 | 27 | 22 | |||
| Additional paid in capital | 43,967 | 36,375 | 30,108 | 14,941 | 10,779 | 6,531 | |||
| Accumulated deficit | (43,860) | (35,640) | (29,136) | (15,435) | (11,232) | ||||
| Other undisclosed equity, attributable to parent | (6,405) | ||||||||
| Other undisclosed equity | (206) | ||||||||
| Total equity: | 109 | 903 | 1,094 | (446) | (426) | (58) | |||
| TOTAL LIABILITIES AND EQUITY: | 10,127 | 9,031 | 8,227 | 6,445 | 2,081 | 2,113 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 23,990 | 8,816 | 4,819 | 736 | 1,030 | 7 | ||
| Revenue, net | ✕ | ✕ | 8,806 | 4,818 | 731 | 655 | 7 | |
| Cost of revenue | (4,325) | (1,270) | (395) | (2) | ||||
| Cost of product and service sold | (292) | (2) | ||||||
| Amortization of value of business acquired (voba) | (1,270) | (103) | ||||||
| Gross profit: | 19,665 | 8,816 | 3,549 | 736 | 635 | 5 | ||
| Operating expenses | (25,357) | (13,916) | (10,653) | (5,010) | (4,815) | (3,894) | ||
| Other operating income (expense), net (Other Expenses) | (7) | 2 | (8) | |||||
| Other undisclosed operating income | 7 | 1,268 | 8 | |||||
| Operating loss: | (5,692) | (5,099) | (5,834) | (4,275) | (4,180) | (3,889) | ||
| Nonoperating income (expense) | (2,587) | (1,402) | (7,865) | (685) | 98 | |||
| Debt instrument, convertible, beneficial conversion feature | 98 | |||||||
| Other nonoperating expense | (13) | (1,402) | (7,865) | (685) | ||||
| Interest and debt expense | (1,332) | (700) | (6,662) | (33) | (939) | (8) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 700 | 6,662 | 33 | |||||
| Loss from continuing operations before equity method investments, income taxes: | (9,611) | (6,501) | (13,699) | (4,960) | (5,119) | (3,799) | ||
| Other undisclosed income from continuing operations before income taxes | 1,332 | |||||||
| Loss from continuing operations before income taxes: | (8,279) | (6,501) | (13,699) | (4,960) | (5,119) | (3,799) | ||
| Income tax expense (benefit) | (1,965) | (3) | (2) | 757 | ||||
| Loss from continuing operations: | (10,244) | (6,504) | (13,701) | (4,203) | (5,119) | (3,799) | ||
| Loss before gain (loss) on sale of properties: | (10,244) | (6,504) | (13,701) | (4,203) | (5,119) | (3,799) | ||
| Other undisclosed net income (loss) | 325 | (158) | ||||||
| Net loss: | (10,244) | (6,504) | (13,701) | (4,203) | (4,794) | (3,956) | ||
| Other undisclosed net income (loss) attributable to parent | 1,965 | (33) | ||||||
| Net loss available to common stockholders, diluted: | (8,279) | (6,504) | (13,701) | (4,203) | (4,827) | (3,956) | ||
Comprehensive Income ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (10,244) | (6,504) | (13,701) | (4,203) | (4,794) | (3,956) | ||
| Comprehensive loss, net of tax, attributable to parent: | (10,244) | (6,504) | (13,701) | (4,203) | (4,794) | (3,956) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.